Background illustration for clinical trials search

Paid Clinical Trials Greeley

Discover 1,482 paid clinical trials in Greeley, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

for
B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma,
Location: Denver CO, Rochester MN, Duarte CA, Los Angeles CA,
Sponsor: Vironexis Biotherapeutics Inc.

Sex: All

Age: 13 - 70+

Code: NCT06533579

Phase 1, Phase 2, Recruiting

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

for
Relapsed/Refractory B-cell Malignancies
Location: Denver CO, Dallas TX, Portland OR, Seattle WA,
Sponsor: Accutar Biotechnology Inc

Sex: All

Age: 18+

Code: NCT05780034

Phase 1, Recruiting

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

for
Relapsed or Refractory Multiple Myeloma,
Location: Denver CO, Duarte CA, Irvine CA, Houston TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05652335

Phase 1, Recruiting

A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events

for
Multiple Myeloma
Location: Denver CO, San Francisco CA, Seattle WA, Cleveland OH,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06500884

Phase 2, Recruiting

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

for
Chronic Lymphocytic Leukemia (CLL),
Location: Denver CO, Salt Lake City UT, Duarte CA, Chicago IL,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04830137

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

for
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia
Location: Denver CO, Albuquerque NM, Des Moines IA, Fargo ND,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT07022678

Phase 3, Recruiting

QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry

for
Acute Kidney Injury, Acute Kidney Injury Due to Sepsis
Location: Denver CO, Fort Worth TX, Dallas TX, Chicago IL,
Sponsor: SeaStar Medical

Sex: All

Age: 0 - 22

Code: NCT06517810

Recruiting

A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

for
Irritable Bowel Syndrome
Location: Aurora CO, Lone Tree CO, Colorado Springs CO,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07519395

Phase 2, Recruiting

The Impact of Medical Play in the Dental Clinic Setting on the Cooperation of Neurotypical Patients

for
Dental Phobia, Dental Anxiety, Oral Aversion
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 5 - 10

Code: NCT05571423

Recruiting

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

for
End Stage Kidney Disease
Location: Arvada CO, Denver CO, North Platte NE, Gallup NM,
Sponsor: CSL Behring

Sex: All

Age: 18+

Code: NCT05485961

Phase 2, Phase 3, Recruiting

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Cheyenne WY, Grand Junction CO, Garden City KS,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 0+

Code: NCT04242095

Recruiting

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

for
Lupus Nephritis
Location: Arvada CO, Dakota Dunes SD, Lubbock TX, Kansas City MO,
Sponsor: Aurinia Pharmaceuticals Inc.

Sex: All

Age: 18 - 70+

Code: NCT07611214

Recruiting

International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

for
Gaucher Disease, Cerebroside Lipidosis Syndrome,
Location: Aurora CO, Salt Lake City UT, Omaha NE, Phoenix AZ,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00358943

Recruiting

PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.

for
Chronic Obstructive Pulmonary Disease
Location: Denver CO, Cleveland OH, New York NY
Sponsor: Observational and Pragmatic Research Institute

Sex: All

Age: 18+

Code: NCT05306743

Recruiting

Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)

for
Primary Membranous Nephropathy
Location: Arvada CO, Salt Lake City UT, El Paso TX, Surprise AZ,
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 18 - 70+

Code: NCT07204275

Phase 2, Phase 3, Recruiting

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

for
Intracerebral Hemorrhage, Atrial Fibrillation
Location: Aurora CO, Salt Lake City UT, Sioux Falls SD, Omaha NE,
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT03907046

Phase 3, Recruiting

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: Aurora CO, Highlands Ranch CO, Colorado Springs CO,
Sponsor: NRG Oncology

Sex: Male

Age: 18+

Code: NCT05946213

Phase 3, Recruiting

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

for
Metastatic Solid Tumor, Advanced Solid Tumor,
Location: Aurora CO, New Lenox IL, Santa Monica CA, Milwaukee WI,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06561685

Phase 1, Recruiting

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

for
Ovarian Carcinoma
Location: Aurora CO, Highlands Ranch CO, Colorado Springs CO,
Sponsor: NRG Oncology

Sex: Female

Age: 35 - 50

Code: NCT04251052

Recruiting

ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)

for
Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
Location: Aurora CO, Saint Paul MN, San Diego CA, Houston TX,
Sponsor: Ionis Pharmaceuticals, Inc.

Sex: Male

Age: 2 - 65

Code: NCT06430385

Phase 1, Phase 2, Recruiting